rs13306575
From SNPedia
					| Orientation | minus | 
| Stabilized | minus | 
| Geno | Mag | Summary | 
|---|---|---|
| (C;C) | 0 | common in clinvar | 
| Make rs13306575(C;T) | 
| Make rs13306575(T;T) | 
| Reference | GRCh38 38.1/142 | 
| Chromosome | 1 | 
| Position | 183563302 | 
| Gene | NCF2 | 
| is a | snp | 
| is | mentioned by | 
| dbSNP | rs13306575 | 
| dbSNP (classic) | rs13306575 | 
| ClinGen | rs13306575 | 
| ebi | rs13306575 | 
| HLI | rs13306575 | 
| Exac | rs13306575 | 
| Gnomad | rs13306575 | 
| Varsome | rs13306575 | 
| LitVar | rs13306575 | 
| Map | rs13306575 | 
| PheGenI | rs13306575 | 
| Biobank | rs13306575 | 
| 1000 genomes | rs13306575 | 
| hgdp | rs13306575 | 
| ensembl | rs13306575 | 
| geneview | rs13306575 | 
| scholar | rs13306575 | 
| rs13306575 | |
| pharmgkb | rs13306575 | 
| gwascentral | rs13306575 | 
| openSNP | rs13306575 | 
| 23andMe | rs13306575 | 
| SNPshot | rs13306575 | 
| SNPdbe | rs13306575 | 
| MSV3d | rs13306575 | 
| GWAS Ctlg | rs13306575 | 
| GMAF | 0.01653 | 
| Max Magnitude | 0 | 
| ? | (C;C) (C;T) (T;T) | 28 | 
|---|---|---|
| 
 
 
  | ||
| ClinVar | |
|---|---|
| Risk | rs13306575(A;A) rs13306575(G;G) rs13306575(T;T) | 
| Alt | rs13306575(A;A) rs13306575(G;G) rs13306575(T;T) | 
| Reference | Rs13306575(C;C) | 
| Significance | Pathogenic | 
| Disease | Chronic granulomatous disease Chronic granulomatous disease | 
| Variation | info | 
| Gene | NCF2 | 
| CLNDBN | Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2 Chronic granulomatous disease | 
| Reversed | 1 | 
| HGVS | NC_000001.10:g.183532437G>A | 
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) | 
| CLNACC | RCV000002336.3, RCV000407030.1, | 
[PMID 16608528
] Genetic polymorphisms and susceptibility to lung disease.
[PMID 17897462
] A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.
[PMID 24163247
] Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations
